Search

everythinglearnresearchcommunity

for

Search:↓

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Hormonal therapies are safe and effective for treating adult women's acne.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Tooth regeneration could become possible by controlling how and when bioactive factors are released.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Melatonin may help treat PCOS symptoms in rats.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Using anabolic-androgenic steroids can cause skin problems like acne and hair loss in athletes.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Melatonin protects skin against UV damage by regulating various cellular processes.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Finasteride may help some women with hair loss, but better options exist.

Thymosin β4 helps improve skin healing and reduce scarring.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The normal human prostate does not significantly affect blood DHT levels.